Does CANAGLIFLOZIN Cause Myocardial infarction? 343 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 343 reports of Myocardial infarction have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 1.4% of all adverse event reports for CANAGLIFLOZIN.
343
Reports of Myocardial infarction with CANAGLIFLOZIN
1.4%
of all CANAGLIFLOZIN reports
34
Deaths
191
Hospitalizations
How Dangerous Is Myocardial infarction From CANAGLIFLOZIN?
Of the 343 reports, 34 (9.9%) resulted in death, 191 (55.7%) required hospitalization, and 26 (7.6%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 343 reports have been filed with the FAERS database.
What Other Side Effects Does CANAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,413)
Toe amputation (2,193)
Osteomyelitis (2,146)
Acute kidney injury (1,853)
Fungal infection (1,385)
Gangrene (1,081)
Weight decreased (1,014)
Cellulitis (1,007)
Urinary tract infection (920)
Diabetic foot infection (832)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which CANAGLIFLOZIN Alternatives Have Lower Myocardial infarction Risk?
CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN
CANAGLIFLOZIN vs CANAKINUMAB
CANAGLIFLOZIN vs CANDESARTAN
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE